Eris Lifesciences allotted 4,816 equity shares at Rs. 450.04 premium per share under its ESOP-2017 Scheme.
The company's paid-up share capital increased from Rs. 13.86 crore to Rs. 13.86 crore after the allotment.
The allotment was approved and digitally signed by Company Secretary Milind Talegaonkar on July 30, 2026.